ODDB.org: Open Drug Database

Gemcitabin DRAC 200mg, Lyophilisat - Durchstechflasche(n)

Swissmedic Key	62825001	Registration Holder	DRAC AG
Name	Gemcitabin DRAC 200mg, Lyophilisat	Date of registration	28.12.2012
		Introduction of Sequence	28.12.2012
ATC-Classification	Gemcitabine (L01BC05)	Revision date
WHO	WHO-DDD	Valid until	27.12.2017
Index Therapeuticus (BSV)		Show package size	Durchstechflasche(n)
Index Therapeuticus (Swissmedic)	07.16.10.	Description
Swissmedic categorie.	A
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	PR
Deductible	k.A.	Consumer price	PR
Feedback	FB
GTIN	7680628250013	Medication Code	Synthetika human
Pharmacode		Disponibility

Composition

Praeparatio cryodesiccata: gemcitabinum 200 mg ut gemcitabini hydrochloridum, mannitolum, natrii acetas trihydricus, pro vitro.

Packungsbestandteile

Galenic Form	Lyophilisate

Source

Data was imported : 04.12.2014 Swissmedic Registration : 62825 Sequence : 01 Product name : Gemcitabin DRAC 200mg, Lyophilisat Registration owner: : DRAC AG Product group : Index Therapeuticus (BSV) : 07.16.1. Medication Code : Synthetika human Date of registration : 28.12.2012 Valid until : 27.12.2017 Package number : 001 Show package size : 1 Commercial Form/Unit : Durchstechflasche(n) Swissmedic categorie. : A Active Agents : gemcitabinum Composition : Praeparatio cryodesiccata: gemcitabinum 200 mg ut gemcitabini hydrochloridum, mannitolum, natrii acetas trihydricus, pro vitro.

2025	©ywesee GmbH